Corporate Round - Tavros Therapeutics
Investment Firm
Overview
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Announced Date
Oct 12, 2022
Funding Type
Corporate Round
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Tavros Therapeutics raised $17500000 on 2022-10-12 in Corporate Round
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 02, 2020 |  Seed Round - Tavros Therapeutics | 1 | - | 3.0M |
| Sep 27, 2022 | Seed Round - Tavros Therapeutics | 3 | - | 7.5M |
| Oct 12, 2022 | Corporate Round - Tavros Therapeutics | 1 | - | 17.5M |
Recent Activity
There is no recent news or activity for this profile.